5KUY image
Deposition Date 2016-07-13
Release Date 2017-06-14
Last Version Date 2024-11-13
Entry Detail
PDB ID:
5KUY
Keywords:
Title:
Influenza hemagglutinin H3 A/Hong Kong/1/1968 in complex with designed inhibitor protein HSB.2A
Biological Source:
Method Details:
Experimental Method:
Resolution:
2.60 Å
R-Value Free:
0.20
R-Value Work:
0.17
R-Value Observed:
0.17
Space Group:
C 1 2 1
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Hemagglutinin HA1
Gene (Uniprot):HA
Chain IDs:A, C, E
Chain Length:323
Number of Molecules:3
Biological Source:Influenza A virus (strain A/Hong Kong/1/1968 H3N2)
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Hemagglutinin HA2
Gene (Uniprot):HA
Mutagens:R452G
Chain IDs:B, D, F
Chain Length:177
Number of Molecules:3
Biological Source:Influenza A virus (strain A/Hong Kong/1/1968 H3N2)
Polymer Type:polypeptide(L)
Molecule:Designed influenza inhibitor HSB.2A
Chain IDs:G, H, I
Chain Length:97
Number of Molecules:3
Biological Source:synthetic construct
Ligand Molecules
Primary Citation
Computational design of trimeric influenza-neutralizing proteins targeting the hemagglutinin receptor binding site.
Nat. Biotechnol. 35 667 671 (2017)
PMID: 28604661 DOI: 10.1038/nbt.3907

Abstact

Many viral surface glycoproteins and cell surface receptors are homo-oligomers, and thus can potentially be targeted by geometrically matched homo-oligomers that engage all subunits simultaneously to attain high avidity and/or lock subunits together. The adaptive immune system cannot generally employ this strategy since the individual antibody binding sites are not arranged with appropriate geometry to simultaneously engage multiple sites in a single target homo-oligomer. We describe a general strategy for the computational design of homo-oligomeric protein assemblies with binding functionality precisely matched to homo-oligomeric target sites. In the first step, a small protein is designed that binds a single site on the target. In the second step, the designed protein is assembled into a homo-oligomer such that the designed binding sites are aligned with the target sites. We use this approach to design high-avidity trimeric proteins that bind influenza A hemagglutinin (HA) at its conserved receptor binding site. The designed trimers can both capture and detect HA in a paper-based diagnostic format, neutralizes influenza in cell culture, and completely protects mice when given as a single dose 24 h before or after challenge with influenza.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
Feedback Form
Name
Email
Institute
Feedback